MalhotraAKAmedSBucevskaMBushKLArnejaJS.Do adolescents with gynecomastia require routine evaluation by endocrinology?Plast Reconstr Surg. 2018;142(1):9e-16e.
2.
DicksonG.Gynecomastia. Am Fam Physician. 2012;85(7):716-722.
3.
KanakisGANordkapLBangAK, et al. EAA clinical practice guidelines—gynecomastia evaluation and management. Andrology. 2019;7(6):778-793.
4.
MaNSGeffnerME.Gynecomastia in prepubertal and pubertal men. Curr Opin Pediatr. 2008;20(4):465-470.
5.
NordtCADiVastaAD.Gynecomastia in adolescents. Curr Opin Pediatr. 2008;20(4):375-382.
6.
ReinehrTKulleABarthAAckermannJLassNHolterhusPM.Sex hormone profile in pubertal boys with gynecomastia and pseudogynecomastia. J Clin Endocrinol Metab. 2020;105(4):dgaa044.
7.
SolimanATDe SanctisVYassinM.Management of adolescent gynecomastia: an update. Acta Biomed. 2017;88(2):204-213.
8.
BraunsteinGD.Clinical practice. Gynecomastia. N Engl J Med. 2007;357(12):1229-1237.
9.
NeymanAFuquaJSEugsterEA.Bicalutamide as an androgen blocker with secondary effect of promoting feminization in male-to-female transgender adolescents. J Adolesc Health. 2019;64(4):544-546.
10.
KrøigaardSMClemmensenLTarpSPagsbergAK.A meta-analysis of antipsychotic-induced hypo- and hyperprolactinemia in children and adolescents. J Child Adolesc Psychopharmacol. 2022;32(7):374-389.
TrinchieriAPerlettiGMagriVStamatiouKTrinchieriMMontanariE.Drug-induced gynecomastia: a systematic review and meta-analysis of randomized clinical trials. Arch Ital Urol Androl. 2021;93(4):489-496.
13.
BergerOLandauZTalismanR.Gynecomastia: a systematic review of pharmacological treatments. Front Pediatr. 2022;10:978311.
14.
PlourdePVReiterEOJouHC, et al. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89(9):4428-4433.